ATYR
Price
$3.28
Change
-$0.06 (-1.80%)
Updated
May 9 closing price
Capitalization
291.46M
93 days until earnings call
MGTX
Price
$5.42
Change
-$0.05 (-0.91%)
Updated
May 9 closing price
Capitalization
433.34M
Earnings call today
Ad is loading...

ATYR vs MGTX

Header iconATYR vs MGTX Comparison
Open Charts ATYR vs MGTXBanner chart's image
aTyr Pharma
Price$3.28
Change-$0.06 (-1.80%)
Volume$927.88K
Capitalization291.46M
MeiraGTx Holdings
Price$5.42
Change-$0.05 (-0.91%)
Volume$759.81K
Capitalization433.34M
ATYR vs MGTX Comparison Chart
Loading...
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATYR vs. MGTX commentary
May 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATYR is a StrongBuy and MGTX is a Buy.

Ad is loading...
COMPARISON
Comparison
May 12, 2025
Stock price -- (ATYR: $3.28 vs. MGTX: $5.42)
Brand notoriety: ATYR and MGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATYR: 66% vs. MGTX: 104%
Market capitalization -- ATYR: $291.46M vs. MGTX: $433.34M
ATYR [@Biotechnology] is valued at $291.46M. MGTX’s [@Biotechnology] market capitalization is $433.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATYR’s FA Score shows that 0 FA rating(s) are green whileMGTX’s FA Score has 0 green FA rating(s).

  • ATYR’s FA Score: 0 green, 5 red.
  • MGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, ATYR is a better buy in the long-term than MGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATYR’s TA Score shows that 6 TA indicator(s) are bullish while MGTX’s TA Score has 3 bullish TA indicator(s).

  • ATYR’s TA Score: 6 bullish, 4 bearish.
  • MGTX’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ATYR is a better buy in the short-term than MGTX.

Price Growth

ATYR (@Biotechnology) experienced а -8.89% price change this week, while MGTX (@Biotechnology) price change was -25.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.25%. For the same industry, the average monthly price growth was +9.40%, and the average quarterly price growth was -13.49%.

Reported Earning Dates

ATYR is expected to report earnings on Aug 13, 2025.

MGTX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-6.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGTX($433M) has a higher market cap than ATYR($291M). ATYR YTD gains are higher at: -9.392 vs. MGTX (-11.002). ATYR has higher annual earnings (EBITDA): -66.37M vs. MGTX (-121.84M). MGTX has more cash in the bank: 104M vs. ATYR (72.1M). ATYR has less debt than MGTX: ATYR (13.3M) vs MGTX (84.8M). MGTX has higher revenues than ATYR: MGTX (33.3M) vs ATYR (235K).
ATYRMGTXATYR / MGTX
Capitalization291M433M67%
EBITDA-66.37M-121.84M54%
Gain YTD-9.392-11.00285%
P/E RatioN/AN/A-
Revenue235K33.3M1%
Total Cash72.1M104M69%
Total Debt13.3M84.8M16%
FUNDAMENTALS RATINGS
ATYR vs MGTX: Fundamental Ratings
ATYR
MGTX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
59
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
4261
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MGTX's Valuation (59) in the Biotechnology industry is in the same range as ATYR (83) in the null industry. This means that MGTX’s stock grew similarly to ATYR’s over the last 12 months.

MGTX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ATYR (100) in the null industry. This means that MGTX’s stock grew similarly to ATYR’s over the last 12 months.

MGTX's SMR Rating (99) in the Biotechnology industry is in the same range as ATYR (100) in the null industry. This means that MGTX’s stock grew similarly to ATYR’s over the last 12 months.

ATYR's Price Growth Rating (42) in the null industry is in the same range as MGTX (61) in the Biotechnology industry. This means that ATYR’s stock grew similarly to MGTX’s over the last 12 months.

ATYR's P/E Growth Rating (100) in the null industry is in the same range as MGTX (100) in the Biotechnology industry. This means that ATYR’s stock grew similarly to MGTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATYRMGTX
RSI
ODDS (%)
Bullish Trend 5 days ago
70%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
84%
MACD
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
79%
Advances
ODDS (%)
Bullish Trend 13 days ago
79%
Bullish Trend 12 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
74%
View a ticker or compare two or three
Ad is loading...
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA298.2613.44
+4.72%
Tesla
GME27.540.76
+2.84%
GameStop Corp
AAPL198.531.04
+0.53%
Apple
SPY564.34-0.72
-0.13%
SPDR® S&P 500® ETF
BTC.X104106.360000-589.968750
-0.56%
Bitcoin cryptocurrency

ATYR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATYR has been loosely correlated with MGTX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ATYR jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATYR
1D Price
Change %
ATYR100%
-1.80%
MGTX - ATYR
46%
Loosely correlated
-0.91%
NTLA - ATYR
40%
Loosely correlated
-1.93%
CRNX - ATYR
38%
Loosely correlated
-6.18%
ERAS - ATYR
38%
Loosely correlated
N/A
SLDB - ATYR
37%
Loosely correlated
-0.36%
More

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with RGNX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
-0.91%
RGNX - MGTX
50%
Loosely correlated
+5.17%
AURA - MGTX
48%
Loosely correlated
-9.83%
KRRO - MGTX
47%
Loosely correlated
+1.04%
IDYA - MGTX
47%
Loosely correlated
-4.18%
ATYR - MGTX
46%
Loosely correlated
-1.80%
More